Baxano Surgical Announces Participation in Canaccord Genuity Musculoskeletal Conference

RALEIGH, N.C., March 7, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the Canaccord Genuity Musculoskeletal Conference on March 11, 2014.

Ken Reali, President and Chief Executive Officer of Baxano Surgical is scheduled to present at the Canaccord Genuity Musculoskeletal Conference in New Orleans, Louisiana on Tuesday, March 11, 2014 at 2:00 pm CT.

Institutional investors that wish to request a meeting with Baxano Surgical should contact Canaccord Genuity.

About Baxano Surgical, Inc.

Baxano Surgical, Inc. is a medical device company focused on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF® family of products for single and two level lower lumbar fusion, the VEO® lateral access and interbody fusion system, iO-Flex®, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures and the iO-Tome® instrument, which rapidly and precisely removes bone, specifically the facet joints, which is commonly performed in spinal fusion procedures. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina. For more information, visit

AxiaLIF, VEO, iO-Flex and iO-Tome are registered trademarks of Baxano Surgical.

CONTACT: Baxano Surgical Inc. Tim Shannon, Interim Chief Financial Officer 919-926-8762 or Westwicke Partners Mark Klausner 443-213-0501 baxanosurgical@westwicke.comSource:Baxano Surgical, Inc.